Search research articles

Search research articles

Related Experiment Videos

Effective decision-making: progressing compounds through clinical development.

C A. Shillingford¹, C W. Vose

¹Phase I Services, Quintiles, Station House, Market Street, RG12 1HX, Bracknell, UK

Drug Discovery Today

|September 8, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Drug discovery today·2026

Same journal

Organoid-AI platforms need integrated governance in drug discovery.

Drug discovery today·2026

Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026

Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026

Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026

Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026

See all related articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Drug development companies must adapt their structures and culture for future challenges to ensure efficiency and investment returns. This review examines key strategies and decision-making processes for navigating the evolving pharmaceutical landscape.

Area of Science:

Pharmaceutical Science
Business Strategy
Organizational Behavior

Background:

The contemporary drug development sector faces significant pressure to enhance operational efficiency and sustain return on investment.
Future market conditions are anticipated to intensify these pressures, necessitating proactive adaptation by pharmaceutical companies.

Purpose of the Study:

To explore strategies and critical issues for reinventing pharmaceutical company structures and culture.
To examine decision-making processes within drug development in response to anticipated future challenges.

Main Methods:

Literature review of current trends in pharmaceutical industry.
Analysis of organizational and strategic adaptation in drug development.
Exploration of decision-making frameworks relevant to the pharmaceutical sector.

Related Experiment Videos

Main Results:

Companies that proactively restructure and foster adaptive cultures are better positioned for future success.
Effective decision-making is identified as a crucial element in navigating industry pressures.
Strategic adaptation is essential for maintaining efficiency and investment returns in drug development.

Conclusions:

Pharmaceutical companies must embrace organizational and cultural transformation to thrive in an increasingly demanding environment.
Strategic foresight and adaptive decision-making are paramount for long-term viability in drug development.
Reinventing structures and culture is key to meeting future challenges and ensuring sustained success in the pharmaceutical industry.